Angiotensin converting enzyme 2 (ACE2) is the putative functional receptor for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Current literature on the abundance and …

COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence
in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous …

The recent emergence of coronavirus disease-2019 (COVID-19) as a pandemic affecting
millions of individuals has raised great concern throughout the world, and the severe acute …

COVID‐19, a new disease caused by the 2019‐novel coronavirus (SARS‐CoV‐2), has
swept the world and challenged its culture, economy, and health infrastructure. Forced …

In a recent issue of Molecular Therapy, 1 Song et al. describe an engineered human
angiotensin-converting enzyme 2 (ACE2), the entry receptor for severe acute respiratory …

Since the end of 2019, coronavirus disease 2019 (COVID‐19) caused by the novel
coronavirus (2019‐nCoV) posed a serious threat to human health and life. Therefore, the …

Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract
several pathophysiological actions of ACE. ACE2 exerts antihypertensive and …

Xiaoqinglong decoction (XQLD), a classic prescription of Traditional Chinese Medicine, has
already been used clinically to cure acute lung injury (ALI), but its mechanism remains …

2019 年 12 月, 湖北省武汉地区暴发新型冠状病毒 (2019-nCoV) 感染疫情. 由于 2019-nCoV
通过棘突糖蛋白与宿主呼吸道上皮细胞的血管紧张素转化酶 (ACE) 2 结合感染人体, ACE2 …

Abstract Coronavirus disease 2019 (COVID-19) is a declared pandemic that is spreading all
over the world at a dreadfully fast rate. Severe acute respiratory syndrome coronavirus-2 …